Navigation Links
Ingenuity Systems Joins Biomarkers Consortium
Date:9/18/2007

REDWOOD CITY, Calif., Sept. 18 /PRNewswire/ -- Ingenuity Systems, the leading provider of solutions to explore, analyze, and interpret scientific literature and data, is pleased to announce its membership in the Biomarkers Consortium, a major public-private biomedical research partnership created to discover, develop, and qualify new biological markers to support new drug development, preventive medicine, and medical diagnostics.

The founding members of the Consortium include the Foundation for the National Institutes of Health (FNIH), National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS); and the Pharmaceutical Research and Manufacturers of America (PhRMA).

"We are pleased to join the Biomarkers Consortium and to have the opportunity to participate in an evolving dialog with key thought leaders from top research organizations and agencies world-wide," stated Art Okamoto, Senior Product Manager at Ingenuity. "We are excited about the prospects offered by the Biomarkers Consortium, and hope to contribute to the development and accessibility of biomarker research in the scientific community."

Ingenuity is committed to helping life science researchers generate maximum value from all types of biological and chemical knowledge. Ingenuity has recently launched IPA-Biomarker(TM) to help researchers identify and prioritize biomarker candidates based on key biological characteristics. Ingenuity's technology supports the Consortium's goal of advancing biomarker research by linking potential markers to a disease or biological process of interest.

About Ingenuity Systems(R)

Ingenuity Systems enables researchers to model, analyze, and understand complex biological and chemical systems foundational to human health and disease. All of Ingenuity's products and services have one common goal -- to provide relevant context and understanding to life science researchers. The Ingenuity products include pathways analysis software and knowledge bases for life scientists and bioinformaticians, in addition to business solutions focused on semantic search and enterprise knowledge management infrastructure. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan. http://www.ingenuity.com.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
3. Performance Comparisons of Commercial RT-PCR Systems
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. In Vivo Signal Transduction Pathway Reporting Systems
6. Improved Vectors for PathDetect Trans-Reporting Systems
7. Genetic Reporter Systems
8. Genetic Reporter Systems
9. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
10. Separation Reproducibility With the BioLogic Chromatography Systems
11. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
Breaking Biology Technology:
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):